Once again, a new DTC (Direct To Consumer) company for personal genetics, Pathway Genomics joined the list of the big companies that are after our genes, in a educational way, if not commercial, as it is said by some big scientists. Comaring to the already existing 23andme and Navigenics, Pathway genomics charge its customers $249 for health test. In addition to this, it will also does genotyping for some risk factors such as markers for over 90 diseases, drug responses. The company is also offering ancestry test for $199 however individuals can get the combo for $348. Pathway Genomics promises affordable tests that can be availed by all people. I hope that is really true and help people by providing cheaper tests. On the contrary, people might get freaked out by knowing their risks which Pathway Genomics promises to help through its counseling service. Well, goodluck Pathway Genomics.
Mechanical pumps to give failing hearts a boost were originally developed as temporary measures for patients awaiting a heart transplant. But as the technology has improved, these ventricular assist devices commonly operate in patients for years, including in former vice-president Dick Cheney, whose implant this month celebrates its one-year anniversary. Prolonged use, however, has its own problems. The power cord that protrudes through the patient's belly is cumbersome and prone to infection over time. Infections occur in close to 40 percent of patients, are the leading cause of rehospitalization, and can be fatal. Researchers at the University of Washington and the University of Pittsburgh Medical Center have tested a wireless power system for ventricular assist devices. They recently presented the work in Washington, D.C. at the American Society for Artificial Internal Organs annual meeting, where it received the Willem Kolff/Donald B. Olsen Award for most promising research in
Comments